|
|
 |
|
Viewing report
|
|
|
|
Who’s Developing What in Global Biopharmaceuticals?
Espicom Business Intelligence Ltd, Sep 2008, Pages: 436
A critical assessment of 50 leading companies, their research, products, partners and performance.
The biopharmaceutical R&D sector is taking an ever more important role in the minds of industry and investors. The potential to fundamentally alter treatment regimes and cure, rather than symptomatically treat, many life-threatening conditions grows greater, but questions remain:
- Who are the companies that are leading development in this critical area?
- What is their area of expertise?
- How substantial is their current product line-up or pipeline projects?
- With whom are they collaborating?
- How can you assess their strengths and weaknesses?
Who’s Developing What in Global Biopharmaceuticals? is a new 475 page management guide to 50 significant companies working in the field. From their structure, through collaboration and detailed pipeline evaluation, the report provides an unmatchable window to the future biopharmaceutical corporate environment.
Important areas covered, where available, for each company include:
- Key Personnel – List of key management
- Company Overview
- Milestones – Summary table of key events in the company’s history
- R&D Pipeline – Products/research by phase and indication
- Technology – Novel discovery/production technology platforms
- Agreements – Who’s working with whom? Important alliances identified
- Key Financial Data – Essential P&L/funding data
- Appraisal & Evaluation – A critical assessment of the company’s platform, pipeline and corporate environment
Answering key questions such as...
- With which major pharmaceutical companies is French company Evotec working, and on what?
- Optimer Pharmaceuticals has eight products in development – what stage are they at and for what are they indicated?
- What benefit has Astex Therapeutics’ Pyramid drug discovery platform brought to the company?
Customers who bought this item also bought
Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
Allergy Drug Pipeline and R&D 2009
Allergy Drug Pipeline and R&D 2009
AstraZeneca: Pipeline, Products, Performance, Potential
Takeda: Pipeline, Products, Performance and Potential
Bayer: Performance, Products, Pipeline and Potential
GlaxoSmithKline: Pipeline, Products, Performance and Potential
Roche - Pipeline - Products - Performance - Potential
Drugs in the Pipeline--An R&D Analysis
Merck KGaA: Pipeline, Products, Performance and Potential
Alcon: Performance, Products, Pipeline and Potential
Amgen: Pipeline, Products, Performance and Potential
|
|
|
|
